5e7n: Difference between revisions
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Crystal Structure of RPA70N in complex with VU0085636== | ==Crystal Structure of RPA70N in complex with VU0085636== | ||
<StructureSection load='5e7n' size='340' side='right' caption='[[5e7n]], [[Resolution|resolution]] 1.21Å' scene=''> | <StructureSection load='5e7n' size='340' side='right'caption='[[5e7n]], [[Resolution|resolution]] 1.21Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5e7n]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5E7N OCA]. For a <b>guided tour on the structure components</b> use [ | <table><tr><td colspan='2'>[[5e7n]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5E7N OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5E7N FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5KR:2-({3-[(4-BROMOPHENYL)SULFAMOYL]-4-METHYLBENZOYL}AMINO)BENZOIC+ACID'>5KR</scene></td></tr> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.21Å</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5KR:2-({3-[(4-BROMOPHENYL)SULFAMOYL]-4-METHYLBENZOYL}AMINO)BENZOIC+ACID'>5KR</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5e7n FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5e7n OCA], [https://pdbe.org/5e7n PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5e7n RCSB], [https://www.ebi.ac.uk/pdbsum/5e7n PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5e7n ProSAT]</span></td></tr> | |||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/RFA1_HUMAN RFA1_HUMAN] Plays an essential role in several cellular processes in DNA metabolism including replication, recombination and DNA repair. Binds and subsequently stabilizes single-stranded DNA intermediates and thus prevents complementary DNA from reannealing.<ref>PMID:19116208</ref> <ref>PMID:19996105</ref> Functions as component of the alternative replication protein A complex (aRPA). aRPA binds single-stranded DNA and probably plays a role in DNA repair; it does not support chromosomal DNA replication and cell cycle progression through S-phase. In vitro, aRPA cannot promote efficient priming by DNA polymerase alpha but supports DNA polymerase delta synthesis in the presence of PCNA and replication factor C (RFC), the dual incision/excision reaction of nucleotide excision repair and RAD51-dependent strand exchange.<ref>PMID:19116208</ref> <ref>PMID:19996105</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 18: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5e7n" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5e7n" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Single-stranded DNA-binding protein 3D structures|Single-stranded DNA-binding protein 3D structures]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Bates | [[Category: Homo sapiens]] | ||
[[Category: Browning | [[Category: Large Structures]] | ||
[[Category: Camper | [[Category: Bates BS]] | ||
[[Category: Chazin | [[Category: Browning CF]] | ||
[[Category: Feldkamp | [[Category: Camper D]] | ||
[[Category: Fesik | [[Category: Chazin WJ]] | ||
[[Category: Gilston | [[Category: Feldkamp MD]] | ||
[[Category: Kuznetsov | [[Category: Fesik SW]] | ||
[[Category: Olejniczak | [[Category: Gilston BA]] | ||
[[Category: Patrone | [[Category: Kuznetsov A]] | ||
[[Category: Pelz | [[Category: Olejniczak ET]] | ||
[[Category: Rossanese | [[Category: Patrone JD]] | ||
[[Category: Souza-Fagundes | [[Category: Pelz NF]] | ||
[[Category: Vangamudi | [[Category: Rossanese OW]] | ||
[[Category: Waterson | [[Category: Souza-Fagundes EM]] | ||
[[Category: Vangamudi B]] | |||
[[Category: Waterson AG]] | |||
Latest revision as of 09:15, 5 July 2023
Crystal Structure of RPA70N in complex with VU0085636Crystal Structure of RPA70N in complex with VU0085636
Structural highlights
FunctionRFA1_HUMAN Plays an essential role in several cellular processes in DNA metabolism including replication, recombination and DNA repair. Binds and subsequently stabilizes single-stranded DNA intermediates and thus prevents complementary DNA from reannealing.[1] [2] Functions as component of the alternative replication protein A complex (aRPA). aRPA binds single-stranded DNA and probably plays a role in DNA repair; it does not support chromosomal DNA replication and cell cycle progression through S-phase. In vitro, aRPA cannot promote efficient priming by DNA polymerase alpha but supports DNA polymerase delta synthesis in the presence of PCNA and replication factor C (RFC), the dual incision/excision reaction of nucleotide excision repair and RAD51-dependent strand exchange.[3] [4] Publication Abstract from PubMedReplication protein A (RPA) is an essential single-stranded DNA (ssDNA)-binding protein that initiates the DNA damage response pathway through protein-protein interactions (PPIs) mediated by its 70N domain. The identification and use of chemical probes that can specifically disrupt these interactions is important for validating RPA as a cancer target. A high-throughput screen (HTS) to identify new chemical entities was conducted, and 90 hit compounds were identified. From these initial hits, an anthranilic acid based series was optimized by using a structure-guided iterative medicinal chemistry approach to yield a cell-penetrant compound that binds to RPA70N with an affinity of 812 nM. This compound, 2-(3- (N-(3,4-dichlorophenyl)sulfamoyl)-4-methylbenzamido)benzoic acid (20 c), is capable of inhibiting PPIs mediated by this domain. Identification and Optimization of Anthranilic Acid Based Inhibitors of Replication Protein A.,Patrone JD, Pelz NF, Bates BS, Souza-Fagundes EM, Vangamudi B, Camper DV, Kuznetsov AG, Browning CF, Feldkamp MD, Frank AO, Gilston BA, Olejniczak ET, Rossanese OW, Waterson AG, Chazin WJ, Fesik SW ChemMedChem. 2016 Jan 8. doi: 10.1002/cmdc.201500479. PMID:26748787[5] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||